Ground-Breaking Technology

• Inside each bioreactor, Coskata's proprietary microorganisms are able to simultaneously convert both CO and H2.
• Other biology-based processes that use suspended cultures typically struggle with phage (bacterial virus) infections, requiring a complete shut down of the fermentor to purge the system. Coskata has mitigated this susceptibility with our patent pending designs.

Cost Savings

• Coskata bioreactors operate at lower pressure and lower temperatures, delivering a cost and energy advantage over competitors using chemical catalysis to produce mixed alcohols.

• The Coskata design allows for a step change in reactor performance in terms of ethanol yield (g ethanol/g syngas) and conversion rate. In all, Coskata's bioreactor reduces total commercial fermentor volume to allow one of the most cost efficient conversion processes in the industry.
• Coskata's unique modular facility design allows plants to scale by adding bioreactors, and not by increasing the size or complexity of the plant.